GB9517060D0 - Acylated oligopeptide derivatives - Google Patents

Acylated oligopeptide derivatives

Info

Publication number
GB9517060D0
GB9517060D0 GBGB9517060.1A GB9517060A GB9517060D0 GB 9517060 D0 GB9517060 D0 GB 9517060D0 GB 9517060 A GB9517060 A GB 9517060A GB 9517060 D0 GB9517060 D0 GB 9517060D0
Authority
GB
United Kingdom
Prior art keywords
oligopeptide derivatives
acylated
acylated oligopeptide
derivatives
oligopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9517060.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Priority to GBGB9517060.1A priority Critical patent/GB9517060D0/en
Publication of GB9517060D0 publication Critical patent/GB9517060D0/en
Priority to PCT/EP1996/003473 priority patent/WO1997008193A1/en
Priority to CA002227516A priority patent/CA2227516A1/en
Priority to EP96927694A priority patent/EP0846127A1/en
Priority to AU67425/96A priority patent/AU6742596A/en
Priority to ZA9606967A priority patent/ZA966967B/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
GBGB9517060.1A 1995-08-17 1995-08-17 Acylated oligopeptide derivatives Pending GB9517060D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9517060.1A GB9517060D0 (en) 1995-08-17 1995-08-17 Acylated oligopeptide derivatives
PCT/EP1996/003473 WO1997008193A1 (en) 1995-08-17 1996-08-06 Acylated oligopeptide derivatives having cell signal inhibiting activity
CA002227516A CA2227516A1 (en) 1995-08-17 1996-08-06 Acylated oligopeptide derivatives having cell signal inhibiting activity
EP96927694A EP0846127A1 (en) 1995-08-17 1996-08-06 Acylated oligopeptide derivatives having cell signal inhibiting activity
AU67425/96A AU6742596A (en) 1995-08-17 1996-08-06 Acylated oligopeptide derivatives having cell signal inhibiting activity
ZA9606967A ZA966967B (en) 1995-08-17 1996-08-16 Acylated oligopeptide derivatives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9517060.1A GB9517060D0 (en) 1995-08-17 1995-08-17 Acylated oligopeptide derivatives

Publications (1)

Publication Number Publication Date
GB9517060D0 true GB9517060D0 (en) 1995-10-25

Family

ID=10779519

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9517060.1A Pending GB9517060D0 (en) 1995-08-17 1995-08-17 Acylated oligopeptide derivatives

Country Status (6)

Country Link
EP (1) EP0846127A1 (en)
AU (1) AU6742596A (en)
CA (1) CA2227516A1 (en)
GB (1) GB9517060D0 (en)
WO (1) WO1997008193A1 (en)
ZA (1) ZA966967B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603227D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use
US6136798A (en) * 1996-05-16 2000-10-24 Warner-Lambert Company Compounds inhibiting the association of the PDGF receptor and phosphatidylinositol 3-kinase and their use
US6307090B1 (en) 1999-01-22 2001-10-23 The United States Of America As Represented By The Department Of Health And Human Services Acylated oligopeptide derivatives having cell signal inhibiting activity
WO2000056760A1 (en) 1999-03-23 2000-09-28 The United States Of America, Represented By Secretary, Department Of Health And Human Services Phenylalanine derivatives
US7226991B1 (en) 1999-03-23 2007-06-05 United States Of America, Represented By The Secretary, Department Of Health And Human Services Phenylalanine derivatives
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
EP1223959B1 (en) * 1999-10-22 2007-05-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain
US7871981B2 (en) 1999-10-22 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility, angiogenesis, and metastasis
EP1383792A2 (en) 2000-08-22 2004-01-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Sh2 domain binding inhibitors
US7425537B2 (en) 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
WO2002036142A2 (en) * 2000-11-03 2002-05-10 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
EP2258371A1 (en) 2001-08-10 2010-12-08 Novartis AG Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
US20050119163A1 (en) 2003-09-18 2005-06-02 The Government Of The United States Of America, As Represented By The Secretary, SH2 domain binding inhibitors
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
EP1812012A4 (en) * 2004-11-15 2010-02-17 Ceptyr Inc Protein tyrosine phosphatase inhibitors and methods of use thereof
IN2012DN02139A (en) 2009-09-10 2015-08-07 Novartis Ag
US20120289501A1 (en) 2009-11-25 2012-11-15 Novartis Ag Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
JP2013532149A (en) 2010-06-17 2013-08-15 ノバルティス アーゲー Piperidinyl-substituted 1,3-dihydro-benzimidazol-2-ylideneamine derivatives
EP2582680A1 (en) 2010-06-17 2013-04-24 Novartis AG Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
WO2012120469A1 (en) 2011-03-08 2012-09-13 Novartis Ag Fluorophenyl bicyclic heteroaryl compounds
CN108064274A (en) 2014-07-30 2018-05-22 耶达研究及发展有限公司 For cultivating the culture medium of multipotential stem cell
JP2019525947A (en) * 2016-06-01 2019-09-12 エムスリー・バイオテクノロジー・インコーポレイテッドＭ３ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． Compound
IT201600074606A1 (en) * 2016-07-18 2018-01-18 Italfarmaco Spa New benzo-N-hydroxy amide compounds having antitumor activity
EP3730483B1 (en) 2017-12-21 2023-08-30 Hefei Institutes of Physical Science, Chinese Academy of Sciences Class of pyrimidine derivative kinase inhibitors
WO2020152686A1 (en) 2019-01-23 2020-07-30 Yeda Research And Development Co. Ltd. Culture media for pluripotent stem cells
US20220395553A1 (en) 2019-11-14 2022-12-15 Cohbar, Inc. Cxcr4 antagonist peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007913A1 (en) * 1992-09-25 1994-04-14 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof
AU682906B2 (en) * 1993-10-25 1997-10-23 Parke, Davis & Company Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
AU4972096A (en) * 1995-02-01 1996-08-21 Affymax Technologies N.V. Peptides and compounds that bind to sh2 domains

Also Published As

Publication number Publication date
ZA966967B (en) 1997-02-17
WO1997008193A1 (en) 1997-03-06
EP0846127A1 (en) 1998-06-10
AU6742596A (en) 1997-03-19
CA2227516A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
GB9517060D0 (en) Acylated oligopeptide derivatives
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
ZA969990B (en) Oxymethoxy-3-aryl-pyrone derivatives
GB2306473A8 (en) Glucoxide derivatives
ZA96228B (en) Indolepiperidine derivatives
ZA969278B (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
GB9516842D0 (en) Various acylated oligopeptides
HUP9600107A2 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
SI0758644T1 (en) Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
GR3035577T3 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
ZA964470B (en) Cycloalkane-benzylidene derivatives
EP0747270A3 (en) Inflator
IL117858A0 (en) 4-Indolypiperazinyl derivatives
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
ZA967204B (en) Alkenyl-benzoylguanidine derivatives
IL123000A0 (en) Aza-anthracyclinone derivatives